Cargando…
Model Amphipathic Peptide Coupled with Tacrine to Improve Its Antiproliferative Activity
Drug repurposing and drug combination are two strategies that have been widely used to overcome the traditional development of new anticancer drugs. Several FDA-approved drugs for other indications have been tested and have demonstrated beneficial anticancer effects. In this connection, our research...
Autores principales: | Silva, Sara, Alves, Cláudia, Duarte, Diana, Costa, Ana, Sarmento, Bruno, Almeida, António J., Gomes, Paula, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795729/ https://www.ncbi.nlm.nih.gov/pubmed/33383645 http://dx.doi.org/10.3390/ijms22010242 |
Ejemplares similares
-
Formulation, Characterization and Evaluation against SH-SY5Y Cells of New Tacrine and Tacrine-MAP Loaded with Lipid Nanoparticles
por: Silva, Sara, et al.
Publicado: (2020) -
A Second Life for MAP, a Model Amphipathic Peptide
por: Silva, Sara, et al.
Publicado: (2022) -
Therapeutic Potential of Multifunctional Tacrine Analogues
por: Przybyłowska, Maja, et al.
Publicado: (2019) -
Small amphipathic peptides are responsible for the assembly of cruciferin nanoparticles
por: Hong, Hui, et al.
Publicado: (2017) -
The Many Faces of Amphipathic Helices
por: Giménez-Andrés, Manuel, et al.
Publicado: (2018)